Variant report
Variant | nsv981322 |
---|---|
Chromosome Location | chr6:23781341-23791763 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539974628 | chr6:23781616-23781617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs180995478 | chr6:23781639-23781640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143119068 | chr6:23781644-23781645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563795615 | chr6:23781656-23781657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs200599259 | chr6:23781657-23781658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557419316 | chr6:23781661-23781662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10456039 | chr6:23781663-23781664 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs12200386 | chr6:23781694-23781695 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs555317351 | chr6:23781702-23781703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556813470 | chr6:23781705-23781706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115736882 | chr6:23781715-23781716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574110855 | chr6:23781732-23781733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542407709 | chr6:23781762-23781763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554330011 | chr6:23781773-23781774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185773431 | chr6:23781781-23781782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375065165 | chr6:23783815-23783816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546888543 | chr6:23783842-23783843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs564933472 | chr6:23783864-23783865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532006343 | chr6:23783879-23783880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs140880276 | chr6:23783905-23783906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563812216 | chr6:23783918-23783919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs75218146 | chr6:23783941-23783942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs374517605 | chr6:23783942-23783943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs386406480 | chr6:23783948-23783949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs398072714 | chr6:23783950-23783951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531024930 | chr6:23783958-23783959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs549138278 | chr6:23783966-23783967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567431157 | chr6:23783970-23783971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528604396 | chr6:23784007-23784008 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs546775749 | chr6:23784009-23784010 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114706832 | chr6:23784023-23784024 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs538642525 | chr6:23784031-23784032 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112268454 | chr6:23784038-23784039 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569147657 | chr6:23784067-23784068 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs199680583 | chr6:23784073-23784074 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs398065663 | chr6:23784075-23784076 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs184392934 | chr6:23784076-23784077 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147812701 | chr6:23784081-23784082 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs71812341 | chr6:23784098-23784099 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9356898 | chr6:23784118-23784119 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs6939526 | chr6:23784133-23784134 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs9379581 | chr6:23784138-23784139 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs141359954 | chr6:23784147-23784148 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552661707 | chr6:23784189-23784190 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189488486 | chr6:23784194-23784195 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576093222 | chr6:23784200-23784201 | Active TSS Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543827453 | chr6:23784205-23784206 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs376677309 | chr6:23784236-23784237 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574820457 | chr6:23784265-23784266 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181954389 | chr6:23784267-23784268 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 16790693 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Lung cancer | 19153074 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Uveal melanoma | 20484589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:23781600-23781800 | Enhancers | Fetal Kidney | kidney |
2 | chr6:23783800-23785000 | Enhancers | Fetal Kidney | kidney |
3 | chr6:23784000-23784200 | Active TSS | Aorta | Aorta |
4 | chr6:23784000-23784400 | Enhancers | Fetal Stomach | stomach |
5 | chr6:23784200-23784400 | Flanking Active TSS | Aorta | Aorta |
6 | chr6:23784200-23784800 | Enhancers | Rectal Smooth Muscle | rectum |
7 | chr6:23784200-23786000 | Enhancers | Colon Smooth Muscle | Colon |
8 | chr6:23784400-23784600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr6:23784400-23785000 | Enhancers | Aorta | Aorta |
10 | chr6:23784400-23785200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr6:23784400-23785200 | Weak transcription | Fetal Stomach | stomach |
12 | chr6:23784600-23785200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr6:23785000-23786000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr6:23785000-23786000 | Weak transcription | Fetal Kidney | kidney |
15 | chr6:23785200-23785600 | Enhancers | Fetal Stomach | stomach |
16 | chr6:23785200-23786200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
17 | chr6:23785200-23786200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
18 | chr6:23785400-23786400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr6:23785600-23785800 | Weak transcription | Fetal Stomach | stomach |
20 | chr6:23785800-23786200 | Enhancers | Fetal Stomach | stomach |
21 | chr6:23786000-23786200 | Enhancers | Fetal Kidney | kidney |
22 | chr6:23786200-23790000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
23 | chr6:23790000-23790400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
24 | chr6:23790000-23790600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
25 | chr6:23790200-23791800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
26 | chr6:23790800-23791800 | Enhancers | Fetal Brain Male | brain |
27 | chr6:23791400-23791800 | Enhancers | Aorta | Aorta |